Profund Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
62,848
-25,691
| -29% | -$44.2K | ﹤0.01% | 958 |
|
|
2025
Q1 | $295K | Sell |
88,539
-19,344
| -18% | -$64.4K | 0.01% | 689 |
|
|
2024
Q4 | $798K | Sell |
107,883
-20,921
| -16% | -$155K | 0.03% | 341 |
|
|
2024
Q3 | $1.21M | Buy |
128,804
+4,144
| +3% | +$38.9K | 0.05% | 282 |
|
|
2024
Q2 | $1,000K | Buy |
124,660
+31,010
| +33% | +$249K | 0.04% | 300 |
|
|
2024
Q1 | $1.39M | Sell |
93,650
-108,776
| -54% | -$1.61M | 0.05% | 263 |
|
|
2023
Q4 | $1.65M | Sell |
202,426
-48,084
| -19% | -$391K | 0.07% | 214 |
|
|
2023
Q3 | $1.14M | Buy |
250,510
+59,427
| +31% | +$270K | 0.06% | 255 |
|
|
2023
Q2 | $1.35M | Sell |
191,083
-10,954
| -5% | -$77.1K | 0.07% | 245 |
|
|
2023
Q1 | $1.23M | Buy |
+202,037
| New | +$1.23M | 0.08% | 246 |
|